Endometriosis and ATR-FTIR Spectroscopy
Launched by FEDERAL UNIVERSITY OF ESPIRITO SANTO · May 17, 2024
Trial Information
Current as of February 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new way to detect endometriosis, a condition that causes painful symptoms in women, by using a special technique called mid-infrared spectroscopy (ATR-FTIR). Researchers want to see if they can find signs of endometriosis in urine samples, which could make diagnosis easier and less invasive for patients.
To be eligible for the study, participants must be women aged between 18 and 55 who experience pelvic pain. Those who join the trial will provide urine samples and help researchers understand whether this new detection method is effective. It's important to note that participants will need to give their informed consent, meaning they understand the study and agree to take part. This trial is currently recruiting, so if you or someone you know fits the criteria, it could be a chance to contribute to important research in women's health.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female
- • Pelvic pain complain
- Exclusion Criteria:
- • Age under 18 or above 55
- • Lack of informed consent
Trial Officials
Valerio G Barauna, PhD
Principal Investigator
Universidade Federal do Espírito Santo
About Federal University Of Espirito Santo
The Federal University of Espírito Santo (UFES) is a prominent academic institution in Brazil, dedicated to advancing knowledge through research, education, and community engagement. With a commitment to excellence in various fields, UFES plays a vital role in the development of innovative clinical trials that address critical health challenges. The university fosters interdisciplinary collaboration among researchers, healthcare professionals, and students, aiming to enhance clinical practices and improve patient outcomes. Through its rigorous scientific approach and ethical standards, UFES is a trusted sponsor of clinical trials that contribute to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vitória, Espírito Santo, Brazil
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0